Dr. Todd Johnson, MD, became MDS Pharma Services Senior Vice President for Early Stage Development in February 2008. In this role, he has responsibility for integrating the operations of the Early Clinical Research and Bioanalytical Services lines of business for global growth.
He joined MDS Pharma Services in March 2007 as Senior Vice President for Strategy and Corporate Development. Prior to that, he was with McKinsey & Company, where he spent five years leading strategic consulting engagements with CEO- and SVP-level clients at major pharmaceutical and biotech firms. Before joining McKinsey, he was CEO of Tangerine Technologies, a 40-person biotech software firm that he founded in 1997. He began his career as a Cancer Biologist at Harvard’s Dana-Farber Cancer Institute in Boston, at the University of Pennsylvania in Philadelphia, and at the National Institutes of Health in Bethesda, Maryland.
Educated at the University of Pennsylvania in Philadelphia, he holds an MBA from its Wharton School, an MD from its Medical School, and a BA in Neurobiology from its College of Arts and Sciences’ honors program. During his college career, he also studied Philosophy and Cognitive Neuroscience at St. Catherine’s College of Oxford University in Oxford, UK.
Location: King of Prussia, PA
| Contact: 1-800-554-0502